Literature DB >> 10742221

Isolation of bacteriophages specific to a fish pathogen, Pseudomonas plecoglossicida, as a candidate for disease control.

S C Park1, I Shimamura, M Fukunaga, K I Mori, T Nakai.   

Abstract

Two types of bacteriophage specific to Pseudomonas plecoglossicida, the causative agent of bacterial hemorrhagic ascites disease in cultured ayu fish (Plecoglossus altivelis), were isolated from diseased ayu and the rearing pond water. One type of phage, which formed small plaques, was tentatively classified as a member of the family Myoviridae, and the other type, which formed large plaques, was classified as a member of the family Podoviridae. All 27 strains of P. plecoglossicida examined, which were isolated from diseased ayu from geographically different areas in 1991 to 1999, exhibited quite similar sensitivities to either type of phage. One strain of P. plecoglossicida was highly virulent for ayu, and the 50% lethal dose (LD(50)) when intramuscular injection was used was 10(1.2) CFU fish(-1); in contrast, phage-resistant variants of this organism were less virulent (LD(50), >10(4) CFU fish(-1)). Oral administration of phage-impregnated feed to ayu resulted in protection against experimental infection with P. plecoglossicida. After oral administration of P. plecoglossicida cells of this bacterium were always detected in the kidneys of control fish that did not receive the phage treatment, while the cells quickly disappeared from the phage-treated fish. Bacterial growth in freshwater was lower in the presence of phage, and the number of phage PFU increased rapidly. These results suggest that it may be possible to use phage to control the disease caused by P. plecoglossicida.

Entities:  

Mesh:

Year:  2000        PMID: 10742221      PMCID: PMC92002          DOI: 10.1128/AEM.66.4.1416-1422.2000

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  16 in total

1.  INDIGENOUS MARINE BACTERIOPHAGES.

Authors:  R Spencer
Journal:  J Bacteriol       Date:  1960-04       Impact factor: 3.490

2.  Pseudomonas plecoglossicida sp. nov., the causative agent of bacterial haemorrhagic ascites of ayu, Plecoglossus altivelis.

Authors:  E Nishimori; K Kita-Tsukamoto; H Wakabayashi
Journal:  Int J Syst Evol Microbiol       Date:  2000-01       Impact factor: 2.747

3.  Isolation of Yersinia ruckeri Bacteriophages.

Authors:  R M Stevenson; D W Airdrie
Journal:  Appl Environ Microbiol       Date:  1984-06       Impact factor: 4.792

Review 4.  Bacteriophage therapy and prophylaxis: rediscovery and renewed assessment of potential.

Authors:  P A Barrow; J S Soothill
Journal:  Trends Microbiol       Date:  1997-07       Impact factor: 17.079

5.  Results of bacteriophage treatment of suppurative bacterial infections in the years 1981-1986.

Authors:  S Slopek; B Weber-Dabrowska; M Dabrowski; A Kucharewicz-Krukowska
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  1987       Impact factor: 4.291

6.  Successful treatment of experimental Escherichia coli infections in mice using phage: its general superiority over antibiotics.

Authors:  H W Smith; M B Huggins
Journal:  J Gen Microbiol       Date:  1982-02

7.  Protective effects of bacteriophage on experimental Lactococcus garvieae infection in yellowtail.

Authors:  T Nakai; R Sugimoto; K H Park; S Matsuoka; K Mori; T Nishioka; K Maruyama
Journal:  Dis Aquat Organ       Date:  1999-06-23       Impact factor: 1.802

8.  Isolation and characterization of bacteriophage PM2 from Aeromonas hydrophila.

Authors:  S Merino; S Camprubi; J M Tomás
Journal:  FEMS Microbiol Lett       Date:  1990-03-15       Impact factor: 2.742

9.  Enterococcus seriolicida sp. nov., a fish pathogen.

Authors:  R Kusuda; K Kawai; F Salati; C R Banner; J L Fryer
Journal:  Int J Syst Bacteriol       Date:  1991-07

10.  The control of experimental Escherichia coli diarrhoea in calves by means of bacteriophages.

Authors:  H W Smith; M B Huggins; K M Shaw
Journal:  J Gen Microbiol       Date:  1987-05
View more
  45 in total

1.  Wide geographic distribution of bacteriophages that lyse the same indigenous freshwater isolate (Sphingomonas sp. strain B18).

Authors:  Arite Wolf; Jutta Wiese; Günter Jost; Karl-Paul Witzel
Journal:  Appl Environ Microbiol       Date:  2003-04       Impact factor: 4.792

2.  Use of genetically engineered phage to deliver antimicrobial agents to bacteria: an alternative therapy for treatment of bacterial infections.

Authors:  Caroline Westwater; Laura M Kasman; David A Schofield; Phillip A Werner; Joseph W Dolan; Michael G Schmidt; James S Norris
Journal:  Antimicrob Agents Chemother       Date:  2003-04       Impact factor: 5.191

Review 3.  Pharmacokinetic principles of bacteriophage therapy.

Authors:  Robert J H Payne; Vincent A A Jansen
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

4.  Characterization of a serine hydroxymethyltransferase for L-serine enzymatic production from Pseudomonas plecoglossicida.

Authors:  Wei Jiang; Bingzhao Xia; Junjie Huang; Ziduo Liu
Journal:  World J Microbiol Biotechnol       Date:  2013-08-03       Impact factor: 3.312

Review 5.  Bacteriophages and its applications: an overview.

Authors:  Sonika Sharma; Soumya Chatterjee; Sibnarayan Datta; Rishika Prasad; Dharmendra Dubey; Rajesh Kumar Prasad; Mohan G Vairale
Journal:  Folia Microbiol (Praha)       Date:  2016-10-08       Impact factor: 2.099

6.  Isolation and partial characterization of a virulent bacteriophage IHQ1 specific for Aeromonas punctata from stream water.

Authors:  Irshad Ul Haq; Waqas Nasir Chaudhry; Saadia Andleeb; Ishtiaq Qadri
Journal:  Microb Ecol       Date:  2011-09-27       Impact factor: 4.552

7.  Biosafety evaluation of bacteriophages for treatment of diarrhea due to intestinal pathogen Escherichia coli 3-2 infection of chickens.

Authors:  Hao Li; Man-Li Ma; Hui-Jun Xie; Jian Kong
Journal:  World J Microbiol Biotechnol       Date:  2011-05-15       Impact factor: 3.312

8.  Development of phage delivery by bioencapsulation of artemia nauplii with Edwardsiella tarda phage (ETP-1).

Authors:  Chamilani Nikapitiya; S H S Dananjaya; Shan Lakmal Edirisinghe; H P S U Chandrarathna; Jehee Lee; Mahanama De Zoysa
Journal:  Braz J Microbiol       Date:  2020-07-10       Impact factor: 2.476

9.  Diversity and geographical distribution of Flavobacterium psychrophilum isolates and their phages: patterns of susceptibility to phage infection and phage host range.

Authors:  Daniel Castillo; Rói Hammershaimb Christiansen; Romilio Espejo; Mathias Middelboe
Journal:  Microb Ecol       Date:  2014-02-21       Impact factor: 4.552

Review 10.  Phage therapy and photodynamic therapy: low environmental impact approaches to inactivate microorganisms in fish farming plants.

Authors:  Adelaide Almeida; Angela Cunha; Newton C M Gomes; Eliana Alves; Liliana Costa; Maria A F Faustino
Journal:  Mar Drugs       Date:  2009-07-30       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.